Literature DB >> 23413027

The rare TXNRD1_v3 ("v3") splice variant of human thioredoxin reductase 1 protein is targeted to membrane rafts by N-acylation and induces filopodia independently of its redox active site integrity.

Marcus Cebula1, Naazneen Moolla, Alexio Capovilla, Elias S J Arnér.   

Abstract

The human selenoprotein thioredoxin reductase 1 (TrxR1), encoded by the TXNRD1 gene, is a key player in redox regulation. Alternative splicing generates several TrxR1 variants, one of which is v3 that carries an atypical N-terminal glutaredoxin domain. When overexpressed, v3 associates with membranes and triggers formation of filopodia. Here we found that membrane targeting of v3 is mediated by myristoylation and palmitoylation of its N-terminal MGC motif, through which v3 specifically targets membrane rafts. This was suggested by its localization in cholera toxin subunit B-stained membrane areas and also shown using lipid fractionation experiments. Utilizing site-directed mutant variants, we also found that v3-mediated generation of filopodia is independent of the Cys residues in its redox active site, but dependent upon its membrane raft targeting. These results identify v3 as an intricately regulated protein that expands TXNRD1-derived protein functions to the membrane raft compartment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413027      PMCID: PMC3617239          DOI: 10.1074/jbc.M112.445932

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation.

Authors:  W van't Hof; M D Resh
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development.

Authors:  Cemile Jakupoglu; Gerhard K H Przemeck; Manuela Schneider; Stéphanie G Moreno; Nadja Mayr; Antonis K Hatzopoulos; Martin Hrabé de Angelis; Wolfgang Wurst; Georg W Bornkamm; Markus Brielmeier; Marcus Conrad
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver.

Authors:  S R Lee; J R Kim; K S Kwon; H W Yoon; R L Levine; A Ginsburg; S G Rhee
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

Review 4.  Redox regulation of cellular activation.

Authors:  H Nakamura; K Nakamura; J Yodoi
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells.

Authors:  Y Sugimoto; H Ninomiya; Y Ohsaki; K Higaki; J P Davies; Y A Ioannou; K Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1.

Authors:  Dan Su; Vadim N Gladyshev
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

7.  The human thioredoxin reductase-1 splice variant TXNRD1_v3 is an atypical inducer of cytoplasmic filaments and cell membrane filopodia.

Authors:  Pauliina E Damdimopoulou; Antonio Miranda-Vizuete; Elias S J Arnér; Jan-Ake Gustafsson; Anastasios E Damdimopoulos
Journal:  Biochim Biophys Acta       Date:  2009-08-03

Review 8.  Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.

Authors:  Elias S J Arnér
Journal:  Biochim Biophys Acta       Date:  2009-02-11

Review 9.  Membrane traffic and the cellular uptake of cholera toxin.

Authors:  W I Lencer; T R Hirst; R K Holmes
Journal:  Biochim Biophys Acta       Date:  1999-07-08

10.  Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway.

Authors:  J Shawn Goodwin; Kimberly R Drake; Carl Rogers; Latasha Wright; Jennifer Lippincott-Schwartz; Mark R Philips; Anne K Kenworthy
Journal:  J Cell Biol       Date:  2005-07-18       Impact factor: 10.539

View more
  7 in total

Review 1.  Selenoproteins in colon cancer.

Authors:  Kristin M Peters; Bradley A Carlson; Vadim N Gladyshev; Petra A Tsuji
Journal:  Free Radic Biol Med       Date:  2018-05-22       Impact factor: 7.376

Review 2.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

Review 3.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021

5.  SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress.

Authors:  Toshihiko Kobayashi; Dat Nguyen-Tien; Yuriko Sorimachi; Yuki Sugiura; Takehiro Suzuki; Hitomi Karyu; Shiho Shimabukuro-Demoto; Tatsuki Uemura; Tadashi Okamura; Tomohiko Taguchi; Kohjiro Ueki; Norihiro Kato; Nobuhito Goda; Naoshi Dohmae; Keiyo Takubo; Makoto Suematsu; Noriko Toyama-Sorimachi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

6.  High-fat diet-induced changes in liver thioredoxin and thioredoxin reductase as a novel feature of insulin resistance.

Authors:  Huijun Qin; Xiaolin Zhang; Fei Ye; Liangwei Zhong
Journal:  FEBS Open Bio       Date:  2014-10-31       Impact factor: 2.693

7.  The meiotic regulator JASON utilizes alternative translation initiation sites to produce differentially localized forms.

Authors:  Simon Cabout; Megan P Leask; Shiny Varghese; Jun Yi; Benjamin Peters; Lei Liu Conze; Claudia Köhler; Lynette Brownfield
Journal:  J Exp Bot       Date:  2017-07-10       Impact factor: 6.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.